BACKGROUND RATES OF SELECTED NON-CARDIOVASCULAR (CV) EVENTS IN NON-DIALYSIS (ND) PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)-RELATED ANEMIA RECEIVING ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN THE UNITED STATES (US)

被引：0
|
作者：
Rouette, Julie [1 ]
Mu, George [1 ]
Ma, Liyuan [1 ]
Requena, Gema [1 ]
Richards, Anna [1 ]
Wetten., Sally [1 ]
机构：
[1] GSK, Brentford, England
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2023年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
247
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 42 条
  • [21] SELECTED CARDIOVASCULAR (CV)/NON-CV EVENT RATES IN NON-DIALYSIS-DEPENDENT PATIENTS TREATED WITH ESAS IN US MEDICARE (2017-2019), BY CKD STAGE
    Wetmore, James
    Rouette, Julie
    Guo, Haifeng
    Requena, Gema
    Li, Suying
    Mu, George
    Ma, Liyuan
    Fairburn-Beech, Jolyon
    Richards, Anna
    Gilbertson, David
    Wetten, Sally
    Liu, Jiannong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I610 - I611
  • [22] CARDIOVASCULAR EVENTS IN PATIENTS WITH ANEMIA ASSOCIATED WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE: REGIONAL ANALYSIS OF PATIENTS NOT PREVIOUSLY TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS IN THE PRO2TECT TRIAL
    Winkelmayer, Wolfgang
    Arnold, Susan
    Burke, Steven
    Chertow, Glenn
    Eckardt, Kai-Uwe
    Luo, Wenli
    Minga, Todd
    Parfrey, Patrick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I392 - I393
  • [23] IMPACT OF FDA SAFETY WARNINGS ON ERYTHROPOIESIS STIMULATING AGENTS (ESA) PRESCRIBING AMONG NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS
    Park, H.
    Liu, X.
    VALUE IN HEALTH, 2017, 20 (05) : A310 - A310
  • [24] High Target Hemoglobin With Erythropoiesis-Stimulating Agents Has Advantages in the Renal Function of Non-Dialysis Chronic Kidney Disease Patients (vol 16, pg 529, 2012)
    Tsubakihara, Y.
    Gejyo, F.
    Nishi, S.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2014, 18 (04) : 370 - 370
  • [25] Cardiovascular Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or Not Receiving Dialysis: Pooled Subgroup Analysis of Four Phase 3 Studies
    Esposito, Ciro
    Barratt, Jonathan
    Dellanna, Frank
    Portoles, Jose
    Choukroun, Gabriel
    De Nicola, Luca
    Reusch, Michael
    Young, James
    Jiletcovici, Alina
    Dimkovicl, Nada
    SWISS MEDICAL WEEKLY, 2022, 152 : 23S - 24S
  • [26] Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies
    Barratt, Jonathan
    Dellanna, Frank
    Portoles, Jose
    Choukroun, Gabriel
    De Nicola, Luca
    Young, James
    Dimkovic, Nada
    Reusch, Michael
    ADVANCES IN THERAPY, 2023, 40 (04) : 1546 - 1559
  • [27] Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies
    Jonathan Barratt
    Frank Dellanna
    Jose Portoles
    Gabriel Choukroun
    Luca De Nicola
    James Young
    Nada Dimković
    Michael Reusch
    Advances in Therapy, 2023, 40 (4) : 1546 - 1559
  • [28] Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort study
    Yessayan, Lenar
    Yee, Jerry
    Zasuwa, Gary
    Frinak, Stan
    Besarab, Anatole
    BMC NEPHROLOGY, 2014, 15
  • [29] SAFETY OF ROXADUSTAT VERSUS ERYTHROPOIESIS-STIMULATING AGENTS FOR TREATMENT OF ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE INCIDENT TO OR NOT RECEIVING DIALYSIS: POOLED ANALYSIS OF FOUR PHASE 3 STUDIES
    Barratt, Jonathan
    Dellanna, Frank
    Portoles, Jose
    Choukroun, Gabriel
    De Nicola, Luca
    Reusch, Michael
    Young, James
    Dimkovic, Nada
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I387 - I388
  • [30] Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort study
    Lenar Yessayan
    Jerry Yee
    Gary Zasuwa
    Stan Frinak
    Anatole Besarab
    BMC Nephrology, 15
12345